Koyfin Home > Directory > Health Care > Adamas Pharma > Altman Z-score

Adamas Pharma Altman Z-score Chart (ADMS)

Adamas Pharma annual/quarterly Altman Z-score from 2012 to 2020.
  • Adamas Pharma Altman Z-score for the quarter ending June 06, 2020 was -3.92 a 25.88% decrease of -1.01 year over year
  • Adamas Pharma Altman Z-score for the last 12 months ending June 06, 2020 was -4.65 a 37.07% decrease of -1.72 year over year
  • Adamas Pharma Annual Altman Z-score for 2019 was -3.81 a 103.58% decrease of -3.94 from 2018
  • Adamas Pharma Annual Altman Z-score for 2018 was 0.14 a -1.97% decrease of 0.00 from 2017
  • Adamas Pharma Annual Altman Z-score for 2017 was 0.14 a -13,123.13% decrease of -18.25 from 2016
Other Balance Sheet Metrics:
  • Adamas Pharma Total Assets for the quarter ending September 09, 2018 was $257m a 27.59% increase of 71m year over year
  • Adamas Pharma Other Liabilities for the quarter ending December 12, 2018 was $3m a 76.22% increase of 2m year over year
  • Adamas Pharma Total Equity for the quarter ending September 09, 2018 was $114m a 42.20% increase of 48m year over year
View Chart On Koyfin

Quarterly ADMS Altman Z-score Data

06/2020-3.92
03/2020-3.92
12/2019-3.81
09/2019-2.91
06/2019-2.39
03/2019-1.81
12/2018-0.73
09/20180.60
06/20181.44
03/20181.91

Annual ADMS Altman Z-score Data

2019-3.81
20180.14
20170.14
201618.39
201515.40
201413.38
20133.81
20120.53
2011-36.12